89 related articles for article (PubMed ID: 8570138)
1. Different expression of nm23-H1 and nm23-H2 protein with proliferative activities in various sizes of human renal cell carcinoma.
Hiasa Y; Konishi N; Tao M; Matsuda H; Tsumatani K; Nakamura Y; Kitahori Y; Ozono S; Hirao Y; Okajima E
Oncology; 1996; 53(1):79-87. PubMed ID: 8570138
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer.
Urakami S; Igawa M; Shirakawa H; Shiina H; Kawanishi M
J Urol; 1997 May; 157(5):1928-31. PubMed ID: 9112565
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of nm23 protein expression in renal cell carcinomas.
Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of nm23-H1 protein in renal cell carcinoma.
Kuo JY; Chang KM; Chen KK; Chang LS
Anticancer Res; 1998; 18(1B):531-6. PubMed ID: 9568173
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of nm23-H4 RNA in colorectal and renal tumours.
Hayer J; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 2001; 21(4A):2821-5. PubMed ID: 11724361
[TBL] [Abstract][Full Text] [Related]
6. nm23 protein expression in renal cell tumors: the role of the cell type.
Ayhan A; Usubütün A; Ozen H; Yasui W; Tahara E
Oncol Rep; 1998; 5(4):979-83. PubMed ID: 9625858
[TBL] [Abstract][Full Text] [Related]
7. NM23-H1 and NM23-H2 gene expression in human renal tumors.
Theisinger B; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 1998; 18(2A):1185-9. PubMed ID: 9615786
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
9. [Expression of nm23 in gastrointestinal smooth muscle tumors and its relation to cell proliferative activity].
Wang Q; Sun W; Zhao Y; Wang M; Qin Y; Fu Y
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):427-9. PubMed ID: 11825432
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of nm23 expression in renal cell carcinoma.
Ljungberg B; Osterdahl B; Mehle C
Urol Res; 1999 Apr; 27(2):103-7. PubMed ID: 10424391
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Yagi H; Shirakawa R; Nagasaki M
Oncology; 1997; 54(6):482-9. PubMed ID: 9394845
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
[TBL] [Abstract][Full Text] [Related]
13. Analysis of nm23 expression as a prognostic parameter in renal cell carcinoma.
Park DS; Cho NH; Lee YT; Park C; Lee JM
J Korean Med Sci; 1995 Aug; 10(4):258-62. PubMed ID: 8593205
[TBL] [Abstract][Full Text] [Related]
14. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
15. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
[TBL] [Abstract][Full Text] [Related]
16. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract.
Cheng HL; Tong YC; Tzai TS; Weng CL; Ho CL; Yang WH; Lin JS; Chow NH
Oncol Rep; 2001; 8(1):193-6. PubMed ID: 11115597
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
18. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between intrahepatic metastasis of hepatocellular carcinoma and in situ microenvironment, and the abundance of nm23-H1 H-ras mRNA].
Zheng X; Lin Z; Liu Y
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):15-7. PubMed ID: 10921047
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.
Bosnar MH; Pavelić K; Hrasćan R; Zeljko Z; Krhen I; Marekoyic Z; Krizanac S; Pavelíc J
J Cancer Res Clin Oncol; 1997; 123(9):485-8. PubMed ID: 9341897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
